29.93
-1.2(-3.85%)
Currency In USD
| Previous Close | 31.13 |
| Open | 31.27 |
| Day High | 31.44 |
| Day Low | 29.92 |
| 52-Week High | 46.48 |
| 52-Week Low | 25.28 |
| Volume | 1.13M |
| Average Volume | 1.79M |
| Market Cap | 4.75B |
| PE | 10.81 |
| EPS | 2.77 |
| Moving Average 50 Days | 32.65 |
| Moving Average 200 Days | 34.93 |
| Change | -1.2 |
If you invested $1000 in TG Therapeutics, Inc. (TGTX) 10 years ago, it would be worth $2,593.59 as of December 19, 2025 at a share price of $29.93. Whereas If you bought $1000 worth of TG Therapeutics, Inc. (TGTX) shares 5 years ago, it would be worth $545.17 as of December 19, 2025 at a share price of $29.93.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
TG Therapeutics to Participate in the 8th Annual Evercore Healthcare Conference
GlobeNewswire Inc.
Nov 28, 2025 12:30 PM GMT
Fireside chat scheduled for Tuesday, December 2, 2025 at 12:30 PM ETNEW YORK, Nov. 28, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) today announced that Michael S. Weiss, the Company’s Chairman and Chief Executive Officer, will par
TG Therapeutics Makes 2025 Deloitte Technology Fast 500™ List of America’s Fastest-Growing Companies
GlobeNewswire Inc.
Nov 19, 2025 1:30 PM GMT
NEW YORK, Nov. 19, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced it ranked number 27 on the Deloitte Technology Fast 500™, a ranking of the 500 fastest-growing technology, media, telecommunications, life sciences, f
TG Therapeutics to Participate in the TD Cowen Immunology & Inflammation Summit
GlobeNewswire Inc.
Nov 10, 2025 9:00 PM GMT
Fireside chat scheduled for Wednesday November 12, 2025 at 10:00 AM ETNEW YORK, Nov. 10, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) today announced that Michael S. Weiss, the Company’s Chairman and Chief Executive Officer, will p